SEC Form 4 · accession 0000950138-18-000216
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Angus C. Russell
Director
Period of report
Mar 1, 2018
Accepted (ET)
Mar 5, 2018 · 4:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Mar 1, 2018 | F | 2,576 | $15.68 | D | 22,695 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014.